CANADA: SunOpta CEO to stay on
Canada-based organic foods producer SunOpta yesterday (5 November) said Steve Bromley will now stay on as CEO.
Steve Bromley will remain in his roles as president and CEO and will be re-nominated to the board of directors at the next annual meeting.
The announcement follows a reversal in the board's previously-announced plan for Bromley to "transition" from his executive position by 31 December and not stand for re-election at the next annual meeting.
Bromley has been with the company since 2001 and has since served as chief financial officer, chief operating officer and most recently CEO. The company has ceased any further activities with regards to the recruitment of a new CEO.
Meanwhile, Jeremy Kendall is to remain in his role as chairman of SunOpta following a decision to reverse the board's previous announcement to require the chairman to be independent.
Kendall has served as a director of the company since 1978 and in 1983 was elected chairman of the board and CEO. He retired as CEO in February 2007.
The company said it is continuing to search for a new vice president and chief financial officer, and expects to have a new candidate in place by the end of the fiscal year.
Canada-based organic foods producer SunOpta posted a 31.5% increase in full-year revenue today (6 March) despite a "challenging" year....
SunOpta has appointed Eric Davis to the position of vice president and CFO, effective 16 March....
Canadian natural and organics group SunOpta warned today (20 February) that its 2008 earnings would miss an earlier forecast, due in part to falling commodity prices in the fourth quarter....
- Analysis: Post discusses rationale for Weetabix
- Interview: Sir Kensington's on sale to Unilever
- US food next wave on display at Winter Fancy Food
- Who will buy Danone's Stonyfield business?
- Column: Why snacking is the new meal
- Unilever buys US condiments maker Sir Kensington's
- Ice cream helps Unilever sales, food flat
- Suntory to offload Australia, New Zealand foods
- Nestle organic growth slows but beats expectations
- Post: Weetabix "opens up M&A opportunities"